Alcon CHF 0.20 PAR VALUE
ACL
ACL was delisted on the 8th of April, 2011.
1 hedge funds and large institutions have $168 invested in Alcon CHF 0.20 PAR VALUE in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less capital invested
Capital invested by funds: $14.1M → $168 (-$14.1M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NPA
Nichols & Pratt Advisers
Boston,
Massachusetts
|
-$14.1M |
ACL Hedge Fund Activity: Q3 2023 in Review
1 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Alcon CHF 0.20 PAR VALUE (ACL) for Q3 2023, worth a combined $168 — down 100% from $14.1M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of ACL and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Nichols & Pratt Advisers, exiting entirely with an estimated $14.1M sold.
- 1 institutional investor held Alcon CHF 0.20 PAR VALUE (ACL) as of Q3 2023, down from 2 in Q2 2023.
- Funds reported $168 of Alcon CHF 0.20 PAR VALUE stock for Q3 2023, down 100% quarter-over-quarter.
- 0 funds opened new Alcon CHF 0.20 PAR VALUE positions in Q3 2023 and 1 closed out, a net change of -1 holder.
- The largest Alcon CHF 0.20 PAR VALUE seller in Q3 2023 was Nichols & Pratt Advisers, an estimated $14.1M sold.
Based on aggregated 13F filings for Q3 2023.